Christopher Missling - Mar 28, 2024 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Role
President and CEO, Director
Signature
/s/Christopher Missling
Stock symbol
AVXL
Transactions as of
Mar 28, 2024
Transactions value $
-$278,110
Form type
4
Date filed
4/1/2024, 06:00 PM
Previous filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVXL Common Stock Options Exercise $96.9K +73.4K +5.87% $1.32* 1.32M Mar 28, 2024 Direct
transaction AVXL Common Stock Sale -$375K -73.4K -5.54% $5.11 1.25M Mar 28, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVXL Stock Option (Right to Buy) Options Exercise $0 -73.4K -100% $0.00* 0 Mar 28, 2024 Common Stock 73.4K $1.32 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.03 to $5.195, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.